Molecular Interaction between CD58 and CD2 Counter-Receptors Mediates the Ability of Monocytes to Augment T Cell Activation by IL-12

Journal of Immunology

Volumn 157, Issue 5, 1996, Pages 1886-1893

  Gollob, Jared A ^a,b   Li, Jing ^a   Kawasaki, Hiroshi ^a   Daley, John F ^a   Groves, Chris ^a   Reinherz, Ellis L ^a   Ritz, Jerome ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD2 ANTIGEN; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 12; INTERLEUKIN 12 RECEPTOR; INTERLEUKIN RECEPTOR; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; MONOCLONAL ANTIBODY; PHYTOHEMAGGLUTININ;

ADULT; ANIMAL; ANTIGEN PRESENTING CELL; ARTICLE; BINDING COMPETITION; BIOSYNTHESIS; CHO CELL; CYTOLOGY; DOWN REGULATION; DRUG EFFECT; GENETIC TRANSFECTION; HAMSTER; HUMAN; IMMUNOLOGY; INTERPHASE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; METABOLISM; MIDDLE AGED; MONOCYTE; T LYMPHOCYTE;

ADJUVANTS, IMMUNOLOGIC; ADULT; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD2; ANTIGENS, CD58; BINDING, COMPETITIVE; CHO CELLS; CRICETINAE; DOWN-REGULATION; HUMANS; INTERLEUKIN-12; INTERPHASE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; MIDDLE AGED; MONOCYTES; PHYTOHEMAGGLUTININS; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-12; T-LYMPHOCYTES; TRANSFECTION;

EID: 0030239652     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Kobayashi, M., L. Fitz, M. Ryan, S. C. Hewick, S. Chan, R. Loudon, F. Sherman, B. Perussia, and G. Trinchieri. 1989. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170:827.
2. D'Andrea, A., M. Rengaraju, N. M. Valiante, J. Chehimi, M. Kubin, M. Aste, S. H. Chan, M. Kobayashi, D. Young, E. Nickbarg, R. Chizzonite, S. F. Wolf, and O. Trinchieri. 1992. Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J. Exp. Med. 176:1387.
3. Rook, A. H., K. Kang, M. Kubin, M. Cassin, G. Trinchieri, S. R. Lessin, and K. D. Cooper. 1994. Interleukin 12 mRNA and protein production by epidermal Langerhans' cells. Clin. Res. 42:231a (Abstr.).
4. + T cells. J. Immunol. 154:5071.
5. Perussia, B., S. Chan, A. D'Andrea, K. Tsuji, D. Santoli, M. Pospisil, D. Young, S. Wolf, and G. Trinchieri. 1992. Natural killer cell stimulatory factor or IL-12 has differential effects on the proliferation of TCR-αβ, TCR-γδ lymphocytes and NK cells. J. Immunol. 149:3495.
6. Robertson, M. J., R. J. Soiffer, S. F. Wolf, T. J. Manley, C. Donahue, D. Young, S. H. Hermann, and J. Ritz. 1992. Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation are differentially regulated by NKSF. J. Exp. Med. 175:779.
7. + T lymphocytes. J. Immunol. 151:2444.
8. Chan, S. H., B. Perussia, J. W. Gupta, M. Kobayashi, M. Pospisil, H. A. Young, S. F. Wolf, D. Young, S. C. Clark, and G. Trinchieri. 1991. Induction of IFN-γ production by NK cell stimulatory factor (NKSF): characterization of the responder cells and synergy with other inducers. J. Exp. Med. 173:869.
9. Trinchieri, G. 1993. Interleukin-12 and its role in the generation of Th1 cells. Immunol. Today 14:335.
10. Murray, H. W., and J. Hariprashad. 1995. Interleukin 12 is effective treatment for an established systemic intracellular infection: experimental visceral leishmaniasis. J. Exp. Med. 181:387.
11. Trinchieri, G., and P. Scott. 1994. The role of interleukin 12 in the immune response, disease, and therapy. Immunol. Today 15:460.
12. Brunda, M. J., L. Luistro, R. R. Warrier, R. B. Wright, B. R. Hubbard, M. Murphy, S. F. Wolf, and M. K. Gately. 1993. Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J. Exp. Med. 178:1223.
13. Chua, A. O., R. Chizzonite, B. B. Desai, T. P. Truitt, P. Nunes, L. J. Minetti, R. R. Warrier, D. H. Presky, J. F. Levine, M. K. Gately, and U. Gubler. 1994. Expression cloning of a human IL-12 receptor component: a new member of the cytokine receptor superfamily with strong homology to gp130. J. Immunol. 153:128.
14. Bacon, C. M., D. W. McVicar, J. R. Ortaldo, R. C. Rees, J. J. O'Shea, and J. A. Johnston. 1995. Interleukin 12 (IL-12) induces tyrosine phosphorylation of JAK2 and TYK2: differential use of Janus family tyrosine kinases by IL-2 and IL-12. J. Exp. Med. 181:399.
15. Jacobson, N. G., S. J. Szabo, R. M. Weber-Nordt, Z. Zhong, R. D. Schreiber, J. E. Darnell, Jr., and K. M. Murphy. 1995. Interleukin 12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat)3 and Stat4. J. Exp. Med. 181:1755.
16. Kubin, M., M. Kamoun, and G. Trinchieri. 1994. Interleukin 12 synergizes with B7/CD28 interaction in producing efficient proliferation and cytokine production of human T cells. J. Exp. Med. 180:211.
17. Gollob, J. A., J. Li, E. L. Reinherz, and J. Ritz. 1995. CD2 regulates responsiveness of activated T cells to interleukin 12. J. Exp. Med. 182:721.
18. Springer, T. A., M. L. Dustin, T. K. Kishimoto, and S. D. Marlin. 1987. The lymphocyte function-associated LFA-1, CD2, and LFA-3 molecules: cell adhesion receptors of the immune system. Annu. Rev. Immunol. 5:223.
19. Arulanandam, A. R. N., A. Kister, M. J. McGregor, D. F. Wyss, G. Wagner, and E. L. Reinherz. 1994. Interaction between human CD2 and CD58 involves the major β sheet surface of each of their respective adhesion domains. J. Exp. Med. 180:1861.
20. Osborn, L., E. S. Day, G. T. Miller, M. Karpusas, R. Tizard, S. C. Meuer, and P. S. Hochman. 1995. Amino acid residues required for binding of lymphocyte function-associated antigen 3 (CD58) to its counterreceptor CD2. J. Exp. Med. 181:429.
21. Arulanandam, A. R. N., P. Moingeon, M. F. Concino, M. A. Recny, K. Kato, H. Yagita, S. Koyasu, and E. L. Reinherz. 1993. A soluble multimeric recombinant CD2 protein identifies CD48 as a low affinity ligand for human CD2: divergence of CD2 ligands during the evolution of humans and mice. J. Exp. Med. 177:1439.
22. Moingeon, P., H. Chang, B. P. Wallner, C. Stebbins, A. Z. Frey, and E. L. Reinherz. 1989. CD2-mediated adhesion facilitates T lymphocyte antigen recognition function. Nature 339:312.
23. Koyasu, S., T. Lawton, D. Novick, M. A. Recny, R. F. Siciliano, B. P. Wallner, and E. L. Reinherz. 1989. Role of interaction of CD2 molecules with lymphocyte function-associated antigen 3 in T cell recognition of nominal antigen. Proc. Natl. Acad. Sci. USA 87:2603.
24. Meuer, S. C., R. E. Hussey, M. Fabbi, D. Fox, O. Acuto, K. A. Fitzgerald, J. C. Hodgdon, J. P. Protentis, S. F. Schlossman, and E. L. Reinherz. 1984. An alternative pathway of T cell activation: a functional role for the 50 kD T11 sheep erythrocyte receptor protein. Cell 36:897.
25. Endler-Jobst, B., B. Schraven, B. Hutmacher, and S. C. Meuer. 1991. Human T cell responses to IL-1 and IL-6 are dependent on signals mediated through CD2. J. Immunol. 146:1736.
26. Bierer, B., A. Peterson, J. Gorga, S. Hermann, and S. Burakoff. 1988. Synergistic T cell activation via the physiologic ligands for CD2 and the T cell receptor. J. Exp. Med. 168:1145.
27. Siciliano, R. F., J. C. Pratt, R. E. Schmidt, J. Ritz, and E. L. Reinherz. 1985. Activation of cytolytic T lymphocyte and natural killer cell function through the T11 sheep erythrocyte binding protein. Nature 317:428.
28. Arulanandam, A. R. N., J. M. Withka, D. F. Wyss, G. Wagner, A. Kister, P. Pallai, M. A. Recny, and E. L. Reinherz. 1993. The CD58 (LFA-3) binding site is a localized and highly charged surface area on the AGFCC′C″ face of the human CD2 adhesion domain. Proc. Natl. Acad. Sci. USA 90:11613.
29. Krensky, A. M., F. Sanchez-Madrid, E. Robbins, J. A. Nagy, T. A. Springer, and S. J. Burakoff. 1983. The functional significance, distribution, and structure of LFA-1, LFA-2, and LFA-3: cell surface antigens associated with CTL-target interactions. J. Immunol. 131:611.
30. Dustin, M. L., D. Olive, and T. A. Springer. 1989. Correlation of CD2 binding and functional properties of multimeric and monomeric lymphocyte function-associated antigen 3. J. Exp. Med. 169:503.
31. Chehimi, J., and G. Trinchieri. 1994. Interleukin 12: a bridge between innate resistance and adaptive immunity with a role in infection and acquired immunodeficiency. J. Clin. Immunol. 14:149.
32. Wingren, A. G., K. Dahlenberg, M. Bjorklund, G. Hedlund, T. Kalland, H. Sjogren, A. Ljungdahl, T. Olsson, H. Ekre, D. Sansom, and M. Dohlsten. 1993. Monocyte-regulated IFN-γ production in human T cells involves CD2 signaling. J. Immunol. 150:1328.
33. Spriggs, M. K., R. J. Armitage, L. Strockbine, K. N. Clifford, B. M. MacDuff, T. A. Sato, C. R. Maliszewski, and W. C. Fanslow. 1992. Recombinant human CD40 ligand stimulates B cell proliferation and IgE secretion. J. Exp. Med. 176: 1543.
34. Romagnani, S., M. G. Giudizi, R. Biagiotti, F. Almerigogna, C. Mingari, E. Maggi, C. Liang, and L. Moretta. 1986. B cell growth factor activity of interferon-γ: recombinant human interferon-γ promotes proliferation of anti-μ-activated human B lymphocytes. J. Immunol. 136:3513.
35. Snapper, C. M., and W. E. Paul. 1987. Interferon-γ and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 236:944.
36. Armitage, R. J., B. M. MacDuff, M. K. Spriggs, and W. C. Fanslow. 1993. Human B cell proliferation and Ig secretion by recombinant CD40 ligand are modulated by soluble cytokines. J. Immunol. 150:3671.
37. Grawunder, U., F. Melchers, and A. Rolink. 1993. Interferon-γ arrests proliferation and causes apoptosis in stromal cell/interleukin-7-dependent normal murine pre-B cell lines and clones in vitro, but does not induce differentiation to surface immunoglobulin-positive B cells. Eur. J. Immunol. 23:544.
38. Abed, N. S., J. H. Chace, A. L. Fleming, and J. S. Cowdery. 1994. Interferon-γ regulation of B lymphocyte differentiation: activation of B cells is a prerequisite for IFN-γ-mediated inhibition of B cell differentiation. Cell. Immunol. 153:356.
39. Liu, Y., and C. A. Janeway, Jr. 1990. Interferon-γ plays a critical role in induced cell death of effector T cells: a possible third mechanism of self-tolerance. J. Exp. Med. 172:1735.